Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Which Is Better Target Date Funds Or Age Based Strategy: Brief. A quick look at the trade-offs between these approaches to help you decide what suits you.
27,345 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...
When a tech giant like Meta Platforms hints at neocloud moves, investors crave clarity. This article breaks down what...
As Netflix prepares to report earnings after the bell, investors are dialed in on one question that could shape the s...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
Meta Platforms is nudging into cloud computing, aiming to monetize idle compute and AI-ready infrastructure. This art...
Qualcomm is pivoting from phones to AI chips and software, aiming to blend edge intelligence with data-center power. ...
A Medicare cost shock is hitting many retirees in 2026. This guide breaks down what happened, how it could affect you...
Bitcoin has tumbled as the AI boom pulls money into tech and AI-related plays. This article breaks down what capital ...
Honeywell’s recent spin-offs split the company into four standalone names. This guide breaks down each stock, explain...
A smart way to jump into AI semiconductors starts with a modest, well-balanced plan. Here are three no-brainer AI sto...
SpaceX is taking on massive debt to accelerate its AI ambitions. This in-depth analysis explains the financing move, ...